Doctors, Researchers, and Clinicians
Brandon Prentice, Chief Research Consultant – Mr. Prentice is a University of Denver alumnus with a BS in Biological Sciences. After managing a local, Denver non-profit, he came across our story and developed an interest in genetics. He currently supports our team by analyzing relevant research articles and providing summaries that are instrumental to guiding the development of SLC6A1 treatment. For the time being, he is a medical assistant at a private family practice, but is looking forward to making his mark as a physician after applying to medical school summer 2019.
Dennis Lal, PhD – Dr. Lal is a research scientist at the Genomic Medicine Institute at the Cleveland Clinic.
Ingo Helbig, MD – Dr. Helbig is an attending physician and researcher in the Division of Neurology at Children’s Hospital of Philadelphia.
Katrine Johannesen, MD – Dr. Johannesen is an attending physician and researcher at the Danish Epilepsy Centre, Dianalund, Denmark.
Phillip L. Pearl, MD – Dr. Pearl is a clinician and director of Epilepsy and Clinical Neurophysiology at Boston Children’s Hospital.
Steven Gray, Ph.D. – Dr. Gray is an Associate Professor in the Department of Pediatrics at the University of Texas Southwestern Medical Center. He is currently working with SLC6A1 Connect to develop a gene replacement therapy to treat SLC6A1 mutation.
Family, Friends, and Other Supporters
Tom and Bobbi Clementi – Maxwell’s great uncle and great aunt, who have been amazing in their love and support, as well as extremely helpful with fundraising efforts.
We also owe a debt of gratitude to the many wonderful family members, friends, and others for their donations, interest, and support in our cause!